Xiong et al. (Xiong et al., 2021) reported that berberine inhibited M1 macrophage polarization, promoted M2 macrophage polarization, increased M2/M1ratio, improved the intestinal inflammatory environment, and relieved colitis by inhibiting the NF-κB signaling pathway. Here, NFKB1 is linked to colitis.